Polylactic Acid (PLA)-based Glycol Nanohydrogel Production Service
Multifunctional Properties of Polylactic Acid (PLA)
PLA is an aliphatic polyester produced using a variety of polymerization techniques such as ring-opening polymerization, solid phase polymerization, polycondensation, and azeotropic dehydration condensation. The degradation products of PLA are usually water and carbon dioxide, which are non-toxic and non-carcinogenic to humans. PLA has attracted widespread attention due to its excellent biodegradability, bioabsorbability, biocompatibility, and non-toxic properties. People use PLA for drug delivery, orthopedic fixation devices, surgical sutures, dental implants, or scaffolds for engineering damaged tissues. CD BioGlyco proudly launches PLA-based glycol nanohydrogel production services combining cutting-edge technology and innovative processes to provide clients with the best quality products and solutions.
Fig.1 Sources and applications of PLA. (Balla, et al., 2021)
Leading the Future with PLA-based Glycol Nanohydrogels!
We have developed the GlycoNano™ Platform and provide clients with production services such as Glyconanoparticle, Glycol Nanohydrogel, Glycol Nanorod, etc. Hydrogels are cross-linked polymer networks that absorb or release water in response to stimuli, are easy for cells to attach, and are reshaped into complex structures. Hydrogels carry small amounts of drugs, proteins, and other required ingredients for medical and other purposes, and have a wide range of uses in biomedicine and other fields.
We provide clients with high-quality PLA-based glycol nanohydrogel production services. After detailed communication with clients, we understand their needs and application scenarios and customize the most suitable development plan. Then we select raw materials such as PLA and ethylene glycol to ensure the purity and quality of the materials. According to the characteristics of the product, the most suitable synthesis technology is selected to prepare the nanohydrogel to ensure the stability of its performance. The purification, structure, and physical and chemical properties of the produced products are characterized and tested. Common development technologies include but are not limited to:
Chemical Cross-linking
- Cross-linking via free radical polymerization: It is a four-step polymerization technique that initiates the polymerization process through the presence of free radicals. In hydrogel production, free radical polymerization allows for a controlled cross-linking process, resulting in a network that is both stable and flexible. For example, dextrin is cross-linked with PLA chains through free radical polymerization using potassium persulfate as an initiator.
- Cross-linking with chemical cross-linkers: The hydrophobic PLA is chemically cross-linked with the hydrophilic polymer using chemical cross-linking agents to produce PLA-based glycol nanohydrogels. The process involves the introduction of specific chemical agents that form covalent bonds between polymer chains, such as polyethylene glycol (PEG), lithium diisopropylamide (LDA), and N,N-methylenebisacrylamide.
- Cross-linking via photo-polymerization: Use liquid monomers or macromolecular monomers as initiators under ultraviolet or visible light to produce hydrogels, such as PLA-PEO-PLA hydrogel. The advantages of photopolymerization are fast curing rate, low heat generation, and sequential control of polymerization.
- Cross-linking by graft polymerization: Graft polymerization, the formation of side chains on a preformed polymer backbone, provides an effective method for crosslinking PLA-based ethylene glycol nanohydrogels. This process enhances the hydrophilicity and functionality of the base polymer, allowing the incorporation of a variety of functional groups that tune the hydrogel properties.
Physical Cross-linking
- Hydrophobic interactions: By utilizing the unique hydrophobic properties of PLA and controlling the arrangement of the hydrophilic and hydrophobic parts between polymer chains, the self-assembly of the gel structure is achieved, thereby forming a nano-hydrogel with specific properties. This method is simple and does not require chemical cross-linking agents, making it suitable for applications that require high biocompatibility and low toxicity.
- Cross-linking by ionic interaction: Introducing charged groups into the polymer network to form ionic bonds with ionic species, thereby stabilizing the gel structure. This cross-linking approach enhances the mechanical strength and stability of the hydrogel while allowing precise control of the gel's swelling and sensing properties.
- Hydrogen bonding: Hydrogen bonding technology is a method used to achieve flexible connection of polymer chains in the production of PLA-based ethylene glycol nanohydrogels. The formation of hydrogen bonds increases the stability of the gel network structure, allowing the produced hydrogel to maintain its structural integrity under physiological conditions.
- Stereo-complex formation: The interaction between different stereochemical structures is used to produce PLA-based glycol nanohydrogels. The composites formed in this way have excellent thermal stability and mechanical strength.
Workflow

Applications
- PLA-based glycol nanohydrogel is used in drug delivery systems to achieve precise control of drug release. Due to the high specific surface area of the nanoparticles, nanohydrogels load higher concentrations of drugs and achieve sustained release of drugs by adjusting their cross-linking degree and degradation rate.
- PLA-based glycol nanohydrogel is used to develop effective wound dressing materials. Its excellent hygroscopic properties help maintain a moist environment in the wound and promote the growth of new tissues and cell migration.
- PLA-based glycol nanohydrogel is used in the field of tissue engineering. The porosity of its structure promotes the exchange of nutrients and metabolic wastes and supports cell attachment and proliferation.
Advantages
- The use of advanced physical and chemical cross-linking technologies such as free radical polymerization, chemical cross-linking agents, photopolymerization, and graft polymerization ensures that the produced nanohydrogels have superior physical and chemical properties.
- Our team is composed of experienced experts in the industry with deep knowledge of materials science and bioengineering, ensuring that every innovative step has a scientific basis and technical support.
- We help clients develop hydrogels for multiple application scenarios such as drug delivery, wound healing, and tissue engineering, providing strong support for the success of clients' projects.
Publication Data
DOI: 10.3390/polym15244631
Journal: Polymers
Published: 2023
IF: 4.7
Results: The authors fabricated composite scaffolds with a PLA core and a gelatin-chitosan hydrogel shell by fused deposition modeling (FDM) of a PLA lattice structure and grafting of bioactive gelatin-chitosan hydrogels. The scaffolds exhibited a highly interconnected porous structure after freeze-drying, completely encapsulating the PLA core. This strategy allows for easy customization of scaffold properties for specific target applications by properly designing the lattice geometry and core/shell ratio.
Fig.2 Fabrication process of composite core-shell scaffolds. (Pasini, et al., 2023)
Frequently Asked Questions
- What are the advantages of PLA-based glycol nanohydrogels compared to traditional hydrogels?
PLA-based glycol nanohydrogels not only have better permeability and biodegradability than traditional hydrogels but also provide more precise drug release control and stronger mechanical strength. -
What types of drugs can PLA-based glycol nanohydrogels load?
PLA-based glycol nanohydrogels load a variety of drugs such as small molecule drugs, protein and peptide drugs, nucleic acid drugs (such as DNA and RNA), and some biomacromolecules. These drugs are more effectively delivered and slowly released with the help of hydrogels, improving the therapeutic effect.
With a professional team and advanced technology, CD BioGlyco provides reliable support for PLA-based glycol nanohydrogel production. If you have any needs or questions, please feel free to contact us.
References
- Balla, E.; et al. Poly (lactic Acid): A versatile biobased polymer for the future with multifunctional properties—From monomer synthesis, polymerization techniques and molecular weight increase to PLA applications. Polymers. 2021, 13(11): 1822.
- Pasini, C.; et al. New poly (lactic acid)–hydrogel core–shell scaffolds highly support MSCs' viability, proliferation and osteogenic differentiation. Polymers. 2023, 15(24): 4631.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




